Natalie Cohen, Ph.D., MBA, has over 10 years of hands-on industry experience encompassing many aspects of biologics development, in the technical, quality and regulatory requirements for the physiochemical and functional analysis of biopharmaceutical products, both innovative and biosimilar. She has extensive experience in evaluation of analytical methods and method validation for products ranging from pre-clinical to clinical and commercial phases. Her specialties include biotechnology product characterization, comparability, release and stability testing necessary for product development and commercialization.
